Peter Rahfeld retweetledi
Great talk by @PRahfeld at the #ATC2023SanDiego about ABOi #kidney #transplant. Let's act of the donor and not on the recipient!
English
Peter Rahfeld
77 posts
Peter Rahfeld
@PRahfeld
Biochemist utilizing CAZymes for human health. | @AvivoBio | @withlabb | @UBCMSL |
Vancouver, British Columbia Katılım Mart 2019
144 Takip Edilen150 Takipçiler
Peter Rahfeld retweetledi
@PRahfeld of @ubcmsl / @AvivoBio presents fascinating data on proof of concept for blood group conversion for human kidneys using ex-vivo machine perfusion at #ATC2023SanDiego
English
Peter Rahfeld retweetledi
Conversion of kidneys to be universal donors. @PRahfeld #ATC2023SanDiego
Future opinions for solid organ transplantation @AvivoBio
English
Peter Rahfeld retweetledi
Dreaming of a green 🌍💚 and bright future ? ☘️ 🦠🧫
Listen to a new episode of #Benchtalks featuring #SarahDAdamo and @IrmischSandra and dive into the how, what, why of engineering green life using #synbio.
🎙️Link: tinyurl.com/4ye7j7ae
English
Peter Rahfeld retweetledi
Halle – Vancouver – Leiden. 🛫 #MLU-Alumnus Dr. @prahfeld hat nach seinem Biochemie-Studium an der Uni Halle in Kanada ein Biotech-Unternehmen mitgegründet, das der 37-Jährige heute aus den Niederlanden leitet. mlu.de/7t0gi
Deutsch
Peter Rahfeld retweetledi
#UBC researchers have developed a process that could make #blood types obsolete.
@JayKizLab @CBR_UBC @UBCChem @ubcmsl @PRahfeld @withlabb
#BloodResearch #HealthResearch #transplant #BloodTransfusion
bit.ly/universal-blood
English
Peter Rahfeld retweetledi
@AvivoBio is seeking a Technician, Process Development to support the development of upstream and downstream processes, as well as impurity assay development to support the ongoing development of bacterial-produced enzyme-based product. Link: bit.ly/3W0hjST
English
Peter Rahfeld retweetledi
ABOzymes is now Avivo! Avivo means “from life and for life”. This name update reflects the evolution of the company, while maintaining our founding vision. Visit our new website: avivobio.com and be sure to play the video on the homepage.
English
Peter Rahfeld retweetledi
We’re hiring! We are looking for a Project Manager and a Technician to join us on our journey to make blood types obsolete for blood transfusions and organ transplants. Postings listed at the @lifesciences_bc job board lifesciencesbc.ca/jobs/job-board/
English
Peter Rahfeld retweetledi
Haiming Luo from @UBC presenting on engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection.
#CGSBanff #glycotime @JayKizLab
English
Peter Rahfeld retweetledi
Daniel Luo from @JayKizLab talks about engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection!!! #glycotime
English
Lars Kruse @the_real_larsk @BohlmannLab did present latest results on the production of Montbretin A, a anti-diabetic compound, at the GlycoNet Symposium @glyconet_nce. Great Talk !
#CGSBanff
English
Peter Rahfeld retweetledi
Our review on Carbohydrate-active enzymes in the gut microbiome is live! @withlabb @jacobwardman1 @PRahfeld #glycotime
Nature Reviews Microbiology@NatureRevMicro
Carbohydrate-active enzymes (CAZymes) in the gut microbiome rdcu.be/cJ4Qy Withers and colleagues discuss the vast diversity and activities of CAZymes and their potential applications.
English
Peter Rahfeld retweetledi
So happy to get this review out with @rheabains @PRahfeld @withlabb! Move over hot girl summer, it's Carbohydrate-Active Enzyme spring 🤓!
Nature Reviews Microbiology@NatureRevMicro
Carbohydrate-active enzymes (CAZymes) in the gut microbiome rdcu.be/cJ4Qy Withers and colleagues discuss the vast diversity and activities of CAZymes and their potential applications.
English
Peter Rahfeld retweetledi
Understanding how sugars (glycans) influence blood type and organ donor compatibility is enabling incredible innovations in #health. Exciting work from GlycoNet researchers @withlabb @JayKizLab @PRahfeld @LjwestWest & others.
#glycotime #glycomics
UBC Science@ubcscience
A new study by Canadian scientists has proven it's possible to convert #blood type safely in donor organs intended for transplantation. science.ubc.ca/news/creating-… #UBC @UBCChem @ABOzymes @UHNTransplant #Transplant
English
Peter Rahfeld retweetledi
🅾️A new study shows it's possible to convert #blood type safely in donor organs intended for #transplantation.
Dr. Jayachandran Kizhakkedathu (@JayKizLab) - as well as collaborators @PRahfeld, @withlabb, & many others - are part of this exciting work.
ow.ly/xtqK50HX4A9
English
Peter Rahfeld retweetledi
PhD vacancy, 1 week left to apply! Come and work with us on this beautiful plant, below ground even more fascinating. Details here: universiteitleiden.nl/en/vacancies/2…
#PlantSciJobs #PlantScience #PhDposition #vacancy @LeidenBiology @UniLeiden
English
Peter Rahfeld retweetledi
Looking forward to virtually attending and presenting on behalf of @ABOzymes!
Sara Jane Demy@demy_sara
There are more than 2400 people registered for the upcoming #BiotechShowcase. It's just two days away but there's still time to request your meetings! See here >> bit.ly/3joEFjw @demycolton @EBDgroup
English
Peter Rahfeld retweetledi
VACANCY: Fully funded PhD position in my lab. Fascinated by plant specialized metabolism? Come and work with us! #PlantScience #PlantSciJobs @LeidenBiology @UniLeiden
-> study regulation and transport of a novel anti-diabetic plant derived metabolite universiteitleiden.nl/en/vacancies/2…
English
Peter Rahfeld retweetledi
GlycoNet's Dr. Stephen Withers @UBC is leading Phase 1 trial of a new anti-diabetic compound. By slowing starch breakdown, it could be used to help manage Type 2 #diabetes w/ fewer side effects than other treatments.
Read more: bit.ly/3F4h6VA
#WorldDiabetesDay #Glycomics
English